导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -6.69% | 3505/4773 |
| 近一周 | -2.98% | 4723/5467 |
| 近一月 | 1.54% | 205/5421 |
| 近一季 | 2.79% | 566/5238 |
| 近半年 | -2.19% | 2239/4931 |
| 近一年 | -4.95% | 3130/4400 |
| 近两年 | 35.80% | 2069/2954 |
| 近三年 | 26.64% | 1220/2253 |
| 成立以来 | 22.42% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-8.90% 4328/4961 |
-3.96% 3484/5312 |
- - |
- - |
| 2025 | 11.22% 2759/4813 |
-1.72% 2760/3635 |
9.01% 304/4076 |
0.03% 3907/4524 |
3.78% 624/4813 |
| 2024 | 34.05% 64/3463 |
2.51% 767/2808 |
0.57% 577/3014 |
27.20% 233/3129 |
2.22% 972/3463 |
| 2023 | -4.92% 705/2656 |
-1.04% 1847/2280 |
-0.30% 373/2385 |
5.24% 95/2515 |
-8.43% 2288/2655 |
| 2022 | -12.71% 294/2207 |
-5.47% 193/1919 |
-1.53% 1738/2016 |
-10.82% 453/2113 |
5.15% 486/2208 |
| 2021 | -7.22% 1032/1822 |
-1.35% 472/1255 |
-2.37% 1203/1330 |
-4.38% 704/1466 |
0.74% 1068/1822 |
| 2020 | 4.24% 909/1250 |
-14.53% 966/1028 |
5.39% 883/1067 |
11.02% 486/1164 |
4.23% 855/1184 |
| 2019 | 37.80% 330/1092 |
28.91% 290/754 |
-0.54% 273/804 |
-0.79% 617/850 |
8.34% 325/918 |
| 2018 | -18.48% 145/834 |
- - |
- - |
- - |
-8.44% 93/691 |
| 2017 | 22.09% 154/714 |
- - |
- - |
- - |
- - |
| 2016 | -7.58% 223/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4546 | 31.90% |
| 华富中证港股通创新药指数型发起式A | 1.1637 | 30.96% |
| 天弘恒生沪深港创新药精选50ETF发起联接A | 1.3128 | 30.52% |
| 中欧中证港股通创新药指数发起A | 1.6103 | 30.52% |
| 嘉实中证港股通创新药指数发起式C | 0.8566 | 30.50% |
| 中欧中证港股通创新药指数发起C | 1.4583 | 30.44% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8927 | 30.26% |
| 景顺长城中证港股通创新药ETF联接C | 1.4696 | 29.97% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8736 | 29.94% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8719 | 29.88% |
| 广发中证全指金融地产ETF VS. 长安沪深300非周期A(740101) |